Literature DB >> 31912137

Frequency and Incidence of Carney Complex Manifestations: A Prospective Multicenter Study With a Three-Year Follow-Up.

Stéphanie Espiard1,2,3, Marie-Christine Vantyghem3, Guillaume Assié1,2, Catherine Cardot-Bauters3, Gerald Raverot4, Françoise Brucker-Davis5, Françoise Archambeaud-Mouveroux6, Hervé Lefebvre7, Marie-Laure Nunes8, Antoine Tabarin8, Anne Lienhardt9, Olivier Chabre10, Muriel Houang11, Muriel Bottineau12, Sebastian Stroër13, Lionel Groussin1,2, Laurence Guignat2, Laure Cabanes14, Antoine Feydy13, Fidéline Bonnet15, Marie Odile North16, Nicolas Dupin17, Sophie Grabar12, Denis Duboc14, Jérôme Bertherat1,2.   

Abstract

INTRODUCTION: Carney Complex (CNC) is a rare multiple endocrine and nonendocrine neoplasia syndrome. Manifestations and genotype-phenotype correlations have been described by retrospective studies, but no prospective study evaluating the occurrence of the different manifestations has been available so far.
METHODS: This multicenter national prospective study included patients with CNC, primary pigmented nodular adrenal disease (PPNAD), or a pathogenic PRKAR1A mutation; after a full initial workup, participants were followed for 3 years with annual standardized evaluation.
RESULTS: The cohort included 70 patients (50 female/20 male, mean age 35.4 ± 16.7 years, 81% carrying PRKAR1A mutation). The initial investigations allowed identification of several manifestations. At the end of the 3-year follow-up, the newly diagnosed manifestations of the disease were subclinical acromegaly in 6 patients, bilateral testicular calcifications in 1 patient, and cardiac myxomas in 2 patients. Recurrences of cardiac myxomas were diagnosed in 4 patients during the 3-year follow-up study period. Asymptomatic abnormalities of the corticotroph and somatotroph axis that did not meet criteria of PPNAD and acromegaly were observed in 11.4% and 30% of the patients, respectively. Patients carrying the PRKAR1A c.709-7del6 mutation had a mild phenotype.
CONCLUSION: This study underlines the importance of a systematic follow-up of the CNC manifestations, especially a biannual screening for cardiac myxoma. By contrast, regular screening for the other manifestations after a first extensive workup could be spread out, leading to a lighter and more acceptable follow-up schedule for patients. These are important results for recommendations for long-term management of CNC patients. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Carney complex; Cushing’s syndrome; PRKAR1A; multiple endocrine neoplasia; myxoma

Year:  2020        PMID: 31912137     DOI: 10.1210/clinem/dgaa002

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Palatal Soft Tissue Myxoma in a Patient with Carney Complex.

Authors:  Bruno Augusto Linhares Almeida Mariz; Elena María José Román Tager; Carlos Cordón Fernandez; Oslei Paes de Almeida; Roman Carlos
Journal:  Head Neck Pathol       Date:  2020-10-21

2.  Clinical analysis of the etiological spectrum of bilateral adrenal lesions: A large retrospective, single-center study.

Authors:  Fangfang Yan; Jinyang Zeng; Yulong Chen; Yu Cheng; Yu Pei; Li Zang; Kang Chen; Weijun Gu; Jin Du; Qinghua Guo; Xianling Wang; Jianming Ba; Zhaohui Lyu; Jingtao Dou; Guoqing Yang; Yiming Mu
Journal:  Endocrine       Date:  2022-05-23       Impact factor: 3.925

Review 3.  Carney complex- why thorough medical history taking is so important - report of three cases and review of the literature.

Authors:  B Harbeck; J Flitsch; I Kreitschmann-Andermahr
Journal:  Endocrine       Date:  2022-10-18       Impact factor: 3.925

4.  First Somatic PRKAR1A Defect Associated With Mosaicism for Another PRKAR1A Mutation in a Patient With Cushing Syndrome.

Authors:  Crystal D C Kamilaris; Fabio R Faucz; Victoria C Andriessen; Naris Nilubol; Chyi-Chia Richard Lee; Mark A Ahlman; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2021-01-25

Review 5.  Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.

Authors:  Ozgur Mete; Lori A Erickson; C Christofer Juhlin; Ronald R de Krijger; Hironobu Sasano; Marco Volante; Mauro G Papotti
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 4.056

Review 6.  Genetic and Epigenetic Pathogenesis of Acromegaly.

Authors:  Masaaki Yamamoto; Yutaka Takahashi
Journal:  Cancers (Basel)       Date:  2022-08-10       Impact factor: 6.575

7.  Association between subclinical hyperthyroidism and a PRKAR1A gene variant in Carney complex patients: A case report and systematic review.

Authors:  Hongyang Wang; Min Mao; Dongfang Liu; Lian Duan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.